About Miroculus
Miroculus is a Healthcare company based in San Francisco (United States) founded in 2014 by Fay Christodoulou, and was acquired by Integra Biosciences in March 2023. MicroRNA profiling platform is developed to detect genes in samples. Miroculus has raised $48.42 million across 4 funding rounds from investors including Cota Capital, S32 and Nazca. Miroculus has completed 1 acquisition, including Kapplex. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Gastrointestinal Cancer. Its competitors include Biological Dynamics, Geneoscopy and Mirvie; 3 of its 3 listed competitors have raised funding.
Company details
Miroculus was founded in 2014 in San Francisco, United States, within the biotechnology sector. A MicroRNA profiling platform is developed to identify genes in biological samples. Operations center on the Miro Canvas product, which employs microfluidic technology to automate experimental workflows via cartridges. Minimally invasive molecular testing is facilitated through these processes, supporting diagnostic applications in research and healthcare.
- Headquarters San Francisco, United States
- Founders Fay Christodoulou
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website miroculus.com
- Social LinkedIn X Facebook
- Acquired by Integra Biosciences (Mar 2023)
- Total Equity Funding$48.42M (USD)
in 4 rounds
- Latest Funding Round$20.22M (USD), Series B
Feb 2021
- InvestorsCota Capital
& 3 more
- Investments & Acquisitions
- Acquired byIntegra Biosciences
(Mar 2023)
Funding Insights of Miroculus
Miroculus has successfully raised a total of $48.42M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $20.22 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $48.42M
- Total Rounds 4
- Last Round Series B — $20.22M
- Investors Count 3
All 4 funding rounds of Miroculus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $20.22M | Series B | – | Cota Capital | |
| Feb 2019 | $25.38M | Series B | – | – | – |
| Apr 2015 | $2.82M | Seed | – | – | – |
| Jun 2014 | Seed | – | Nazca | – |
4 investors in total: 4 institutional.
Investors in Miroculus
Miroculus has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Cota Capital, S32 and Nazca.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Stage-agnostic venture capital investments are focused on US sectors. | cotacapital.com | San Francisco, United States | ||
Venture capital investments are made in innovative technology startups. | section32.com | |||
Venture capital firm focused on empowering Latin American founders. | nazca.vc | Coral Gables, United States | ||
Delivers comprehensive laboratory tools for liquid handling and media preparation. | 1965 | integra-biosciences.com | Zizers, Switzerland |
Investor details for Miroculus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Miroculus
6 people are tracked at Miroculus (4 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Fay Christodoulou | Co-Founder & CSO | Leadership |
Mark Lewis | Executive Chairman | Leadership |
Yong Y. | VP, Marketing | Leadership |
Yong Yi | VP of Marketing | Leadership |
Natalia Flores | Financial Analyst II | Team |
Juan F Montoya | Manufacturing Engineering Team Lead | Team |
Complete people profiles for Miroculus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Miroculus
Miroculus has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Kapplex.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Point-of-care diagnostic platforms are developed for healthcare applications. | kapplex.com | Toronto, Canada | 2012 | May 2016 | •••• |
Complete acquisition details for Miroculus
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Miroculus
5 dated milestones of Miroculus across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Miroculus is founded.
- Funding First funding round.
- Acquisition Acquires Kapplex.
- Funding Latest funding round, Series B, of $20.2M.
- Exit Acquired by Integra Biosciences.
Competitors of Miroculus
Miroculus has 3 listed competitors in our database, 3 of them funded. They include Biological Dynamics, Geneoscopy and Mirvie.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biologicaldynamics.com | 2010 | San Diego, United States | $67.65M | 54 | Proprietary lab-on-chip platform for nanoparticle isolation is offered. | |
| geneoscopy.com | 2015 | St. Louis, United States | $218.95M | Non-invasive biomarker tests for colorectal cancer are developed. | ||
| mirvie.com | 2019 | San Francisco, United States | $113.7M | 35 | Non-invasive blood tests for prenatal fetal health predictions are offered. |
Detailed competitors of Miroculus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Miroculus
Websites that share an audience with Miroculus (miroculus.com).
Websites whose visitors overlap most with Miroculus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| integra-biosciences.com | 100% | #432,153 | View details | ||
digitalcorner-wavestone.com | digitalcorner-wavestone.com | 35% | #4,972,293 | – |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Miroculus (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Miroculus
Complete news archive for Miroculus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Miroculus
Miroculus was founded in 2014.
Miroculus is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Miroculus is a funded company, having raised a total of $48.42M across 4 funding rounds to date.
Miroculus was founded in 2014 in San Francisco, United States, within the biotechnology sector. A MicroRNA profiling platform is developed to identify genes in biological samples. Operations center on the Miro Canvas product, which employs microfluidic technology to automate experimental workflows via cartridges. Minimally invasive molecular testing is facilitated through these processes, supporting diagnostic applications in research and healthcare.
Miroculus's top competitors include Geneoscopy, Mirvie and Biological Dynamics.
Miroculus has made 1 acquisition, including Kapplex.
Miroculus has 4 investors. Key investors include Cota Capital, S32, Nazca, and Integra Biosciences.
Yes. Miroculus was acquired by Integra Biosciences in March 2023.